[Adenocarcinoma of the prostate: pathological stage C. 2: Treatment].
The discovery of a pathological stage C after radical prostatectomy with a curative aim for a clinically localized cancer of the prostate raises the question of a possible adjuvant therapy. The indications and modalities of such a therapy still remain controversial. Our review sums up our knowledge and uncertainties on this point.
Flam
T
T
Clinique Urologique, Hôpital Cochin, Paris.
Zerbib
M
M
Steg
A
A
Debré
B
B
D000230:Adenocarcinoma / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D000328:Adult; D000951:Antigens, Neoplasm / Q000276:immunology; D003131:Combined Modality Therapy; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D009364:Neoplasm Recurrence, Local; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery
D000951:Antigens, Neoplasm
Adénocarcinome prostatique: le stade C pathologique. Seconde partie: traitement.